首页> 外文期刊>Scandinavian journal of immunology. >Effects of RNA interference on CD80 and CD86 expression in bone marrow-derived murine dendritic cells.
【24h】

Effects of RNA interference on CD80 and CD86 expression in bone marrow-derived murine dendritic cells.

机译:RNA干扰对骨髓源性鼠树突状细胞CD80和CD86表达的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

To investigate whether RNA interference (RNAi) induced by small interfering RNA (siRNA) could suppress CD80 and CD86 expression in bone marrow-derived murine dendritic cells (DC). The bone marrow-derived DC of mice were separated and cultured in vitro, chemically synthesized siRNA were then transferred into the cells by LipofectAMINE 2000, and the siRNA transfection efficacy was assessed by both fluorescence microscope and flow cytometry. The mRNA expression and protein synthesis were analysed by real-time RT-PCR and flow cytometry. The cell viability of transfected DC was determined by annexin V and propidium iodine staining. Transfection of bone marrow-derived murine DC with a non-silencing FITC-labelled control siRNA demonstrated a high (71.86%) transfection efficiency without affecting cellular viability. CD80-1 siRNA was the most effective siRNA to block CD80 expression in three candidates. Similarly, CD86-3 siRNA was extraordinarily effective in repressing the expression of CD86. Cotransfection of siRNA specific to CD80 and CD86 can enhance gene silencing that is not affected by DC activation-inducing signals. CD80 and CD86 siRNA suppressed the expression of CD80 and CD86 to 31.05 +/- 2.41% and 25.43 +/- 0.85%, respectively, of the level in untreated cells (P < 0.05). siRNA is capable of triggering RNAi in bone marrow-derived DC; it can specifically and effectively knock down CD80 and CD86 gene expression. This approach is a useful tool by which costimulatory molecules of DC can be studied as well as a potential therapeutic option for allograft rejection.
机译:要研究小干扰RNA(siRNA)诱导的RNA干扰(RNAi)是否可以抑制骨髓源性鼠树突状细胞(DC)中的CD80和CD86表达。分离小鼠骨髓来源的DC并在体外培养,然后通过LipofectAMINE 2000将化学合成的siRNA转移到细胞中,并通过荧光显微镜和流式细胞术评估siRNA的转染效率。通过实时RT-PCR和流式细胞术分析mRNA的表达和蛋白质合成。通过膜联蛋白V和碘化丙啶染色确定转染DC的细胞活力。用非沉默FITC标记的对照siRNA转染骨髓来源的鼠DC表现出很高的转染效率(71.86%),而不会影响细胞生存力。 CD80-1 siRNA是在三种候选物中阻断CD80表达的最有效的siRNA。类似地,CD86-3 siRNA在抑制CD86的表达方面非常有效。对CD80和CD86特异的siRNA的共转染可以增强不受DC激活诱导信号影响的基因沉默。 CD80和CD86 siRNA分别将CD80和CD86的表达抑制到未处理细胞水平的31.05 +/- 2.41%和25.43 +/- 0.85%(P <0.05)。 siRNA能够触发骨髓DC中的RNAi。它可以特异性和有效地抑制CD80和CD86基因的表达。这种方法是一种有用的工具,可用于研究DC的共刺激分子以及同种异体移植排斥的潜在治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号